The Leukemia Research Foundation provides one-year grants of up to $100K for new investigator research projects that focus on leukemia, lymphoma, multiple myeloma, and/or myelodysplastic syndromes. The funding cycle is from July to June every year. Below is a timeline of the application process. Exact dates and links to the application materials can be found on the following page application process webpage.
- November: Letter of intent opens and is posted
- February: Letter of intent due
- April: Full application due (if invited)
- June: Grant recipients notified of award
- New investigators are considered to be within seven years of their first independent faculty-level position when the grant would be awarded. Years as a resident physician, fellow physician, or post-doctoral fellow are considered to be training years and are not included in the seven-year guideline.
- Researcher must be in an independent faculty-level position at the time the application is submitted.
- Adjustments for career interruptions can be made. These could include but are not limited to family leave, military service, major illness, or injury. It is the responsibility of the applicant to point out and document such interruptions.
- Applicants are not required to be US citizens. Research projects from outside the US are eligible.
- Applicants with a KO8, K23, R00, or R99 grant are eligible. The total grant amount will not be applied toward the $175K per year threshold on total direct costs.
- DOE, DOD, NSF, R21, or other grants with less than $175K per year in total direct costs are permitted.
- Only one LOI may be submitted from the same applicant.
- The Leukemia Research Foundation does not provide funds for capital equipment (i.e., equipment purchases above $5K). Any request for an exception to this policy must detail the specific need of the capital equipment for the proposed research project.
- The Leukemia Research Foundation does not provide salary support for the principal investigator.
- Using funds for research travel is permitted but should not exceed $1K. The funds are intended only to enhance the study.
- All other support for the project must be detailed, including all sources for the requested and related projects. Any funding overlap must be clearly indicated.
- Indirect cost recovery or institutional overhead costs are not provided.
2022-2023 funding cycle
Grant period: July 1, 2022 – June 30, 2023
- November 22, 2021: Letter of intent opens and is posted
- February 4, 2022: Letter of intent due by 12pm CT
- March 4, 2022: Notification if invited to submit a full application
- April 4, 2022: Full application due (if invited to submit) by 12pm CT
- June 30, 2022: Grant recipients notified of award
Letter of intent
A letter of intent (LOI) allows the Leukemia Research Foundation to assess if there is a good match between our goals and the project. If it appears to be a good match and you are eligible to apply, you will be invited to submit a full application. Please plan to submit your LOI in advance of the deadline in case there are technical issues.
LOI opens: November 22, 2021
LOI due: February 4, 2022 at 12pm CT
Letters of intent and the full application are submitted via ProposalCentral, a research grant management system. A ProposalCentral account is required to submit materials. For assistance with login or technical questions, please contact ProposalCentral customer support at email@example.com or 800.875.2562.